Acrivon TherapeuticsACRV
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 55 institutions reported holding Acrivon Therapeutics Inc. (ACRV) in their 13F filings, unchanged from Q2 2024. 6 opened new positions and 7 sold out. The largest holders were Ra Capital Management, L.P. ($58.4M), Perceptive Advisors LLC ($37.5M) and Citadel Advisors ($15.0M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Acrivon Therapeutics Inc.
- CUSIP
- 004890109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.7M |
| Exits | 7 | $4.3M |
All 13F filers, Q2 2024 → Q3 2024: 606,674 shares bought and 1,117,773 shares sold, net −511,099 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 55 holders
| Ra Capital Management, L.P. | 0.67% | No change | 8,340,508 | $58.4M |
| Perceptive Advisors LLC | 0.81% | No change | 5,360,858 | $37.5M |
| Citadel Advisors | 0.02% | Add +1.0% | 2,140,628 | $15.0M |
| Sands Capital Alternatives, LLC | 4.18% | No change | 2,122,605 | $14.9M |
| Wellington Management Group LLP | 0.00% | No change | 888,130 | $6.2M |
| Marshall Wace, LLP | 0.01% | Reduce -14.7% | 809,859 | $5.7M |
| BlackRock, Inc. | 0.00% | — | 786,982 | $5.5M |
| Vanguard Group Inc. | 0.00% | Reduce -14.5% | 637,538 | $4.5M |
| Geode Capital Management, LLC | 0.00% | Reduce -2.0% | 302,103 | $2.1M |
| State Street Corp. | 0.00% | Add +26.4% | 225,896 | $1.6M |
| Goldman Sachs Group Inc. | 0.00% | Add +712.7% | 198,168 | $1.4M |
| Exome Asset Management LLC | 0.55% | New | 116,757 | $817K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -19.3% | 116,253 | $814K |
| DAFNA Capital Management LLC | 0.19% | Reduce -7.4% | 112,414 | $787K |
| Northern Trust Corp. | 0.00% | Reduce -7.6% | 105,398 | $738K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.01% | Reduce -24.7% | 79,249 | $555K |
| Bridgeway Capital Management, LLC | 0.01% | Add +32.3% | 76,981 | $539K |
| Baker Bros. Advisors LP | 0.00% | No change | 52,885 | $370K |
| Renaissance Technologies | 0.00% | Reduce -15.8% | 45,900 | $321K |
| Millennium Management | 0.00% | New | 39,750 | $278K |
| Prelude Capital Management, LLC | 0.02% | New | 37,727 | $264K |
| Morgan Stanley | 0.00% | Add +108.2% | 35,914 | $251K |
| JPMorgan Chase & Co. | 0.00% | Add +548.3% | 33,991 | $238K |
| Barclays PLC | 0.00% | Add +51.2% | 33,306 | $233K |
| Dimensional Fund Advisors LP | 0.00% | Add +206.2% | 30,824 | $216K |
| Trexquant Investment LP | 0.00% | New | 30,383 | $213K |
| Bank of America Corp. | 0.00% | Add +8.8% | 29,963 | $210K |
| Bank of New York Mellon Corp | 0.00% | Reduce -19.4% | 29,509 | $207K |
| Nuveen Asset Management, LLC | 0.00% | Add +118.1% | 25,779 | $180K |
| Exchange Traded Concepts, LLC | 0.00% | Reduce -52.5% | 20,348 | $142K |
| Rhumbline Advisers | 0.00% | Add +9.6% | 17,760 | $124K |
| American Century Companies Inc. | 0.00% | New | 15,402 | $108K |
| Marex Group Ltd | 0.00% | No change | 13,187 | $92K |
| Citigroup Inc. | 0.00% | Add +120.7% | 11,216 | $79K |
| AAF Wealth Management, LLC | 0.04% | No change | 10,678 | $75K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Reduce -0.6% | 6,471 | $45K |
| Corebridge Financial, Inc. | 0.00% | Reduce -0.6% | 6,316 | $44K |
| UBS Group AG | 0.00% | Reduce -49.2% | 5,662 | $40K |
| Wells Fargo & Company | 0.00% | Add +4.5% | 5,422 | $38K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +25.8% | 4,755 | $33K |
| FMR LLC | 0.00% | Add +56.6% | 2,581 | $18K |
| New York State Common Retirement Fund | 0.00% | No change | 2,314 | $16K |
| Royal Bank of Canada | 0.00% | Add +14.4% | 1,277 | $9K |
| California State Teachers Retirement System | 0.00% | No change | 856 | $6K |
| Legal & General Group Plc | 0.00% | No change | 839 | $6K |
| STRS Ohio | 0.00% | No change | 800 | $6K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 695 | $5K |
| Amalgamated Bank | 0.00% | No change | 378 | $3K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $3K |
| Russell Investments Group, Ltd. | 0.00% | Reduce -77.9% | 258 | $2K |
| Sterling Capital Management LLC | 0.00% | — | 37 | $259 |
| Earned Wealth Advisors, LLC | 0.00% | New | 32 | $224 |
| Cwm, LLC | 0.00% | Add +100.0% | 46 | $0 |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 48 | $0 |
| Avion Wealth | 0.00% | No change | 88 | $0 |
"% of holder's portfolio" is ACRV's weight in each manager's 13F, not the share of Acrivon Therapeutics Inc. the manager owns.